Senior insider sale
CHIEF EXECUTIVE OFFICER at DR REDDYS LABORATORIES LTD — senior position signals high conviction
$13.20M
197.16K shares
What this filing means
ISRAELI EREZ plans to sell 197.16K shares of DR REDDYS LABORATORIES LTD valued at approximately $13.20M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/27/2023ACC: 0001971857-23-000444
Officer· CHIEF EXECUTIVE OFFICER
Since Dec 2025
197.16K
Shares to sell
$13.20M
Approx. market value
197.16K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
EMPLOYMENT INCOME/STOCK BONUS
EMPLOYMENT INCOME/STOCK BONUS
5/21/2018
197.16KTotal acquired197.16K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/21/2018 | EMPLOYMENT INCOME/STOCK BONUS EMPLOYMENT INCOME/STOCK BONUS | 197.16K | — |
| Total | 197.16K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
197.16K
Market value
$13.20M
7/29/2023
Total
Units
197.16K
Value
$13.20M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/29/2023 | 197.16K | $13.20M | NYSE | Planned |
| Total | 197.16K | $13.20M | ||